Research Areas

A Dose Titration Study to Assess the Efficacy, Safety and Tolerability of An Investigational Medication in Obese Patients

A Double-Blind, Multicenter Randomized Parallel Group, 16-Week Study of An Investigational Medication Administered Orally Once A Day With or Without a Low Calorie Diet Lead –In In Obese Males and Females

Randomized, multicenter, double-blind, placebo-controlled, two-arm parallel group trail of rimonabant 20-mg once daily, for inhibitor of atherosclerosis progression assessed by carotid artery intima-media thickness (CIMT), in overweight patients with additional risk factors.

A Randomized, Double-blind, Outpatient, Dose-Titration Trial of an Investigational Medication Versus Placebo in Patients with Essential Hypertension

A Randomized, Double-Blind, Parallel-Filter Study to Evaluate the Antihypertensive Efficacy and Safety of an investigational medication Combination as Compared to an investigational medication in Patients with Essential Hypertension

A 26 week, double-blind, randomized, multicenter, parallel group, active-controlled study comparing an investigational medication to ramipril with optional addition of hydrochlorothiazide, followed by a 4 week double-blind, randomized, placebo-controlled withdrawal in patients with essential hypertension.

A Double-blind Dose-Ranging Study of an Investigational Medication Compared to Placebo and to Lovastatin taken Once Daily in Patients with Hypercholesterolemia

Third Long-Term Extension to: A Double-blind Dose-Ranging Study of an Investigational Medication Compared to Placebo and to Lovastatin Taken Once Daily in Patients with Hypercholesterolemia

A Multicenter, Randomized, Double-Blind, Parallel-Design Study to Evaluate the Lipid-Altering Efficacy of 2 Formulations of an Investigational Medication Compared to NIASPAN

A Multicenter, Randomized, Double-Blind, Parallel-Group, 6-Week Study to Evaluate the Efficacy and Safety an Investigational Medication Combination Tablet Versus Atorvastatin in Patients With Type 2 Diabetes Mellitus (T2DM) and Hypercholesterolemia

Randomized, Multicenter, Double-Blind, Placebo-Controlled, Two-Arm Parallel Group Trial of An Investigational Medication, for Inhibition of Atherosclerosis Progression Assessed by Carotid Artery Intima-Media Thickness (CIMT), in Overweight Patients With Additional Risk Factors

A Double Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of An Investigational Medication When Co-Administered With Atorvastatin (10mg to 40mg) In Subjects With Primary Hypercholesterolemia

A Placebo-Controlled Safety and Efficacy Study of an Investigational Medication in Patients With Type II Diabetes Mellitus and Overt Diabetic Nephropathy

A Placebo-Controlled Trial of an Investigational Medication and Fluoxetine (Prozac) in the Treatment of Patients with Major Depression

A Multicenter, Two-Phase, Randomized, Enriched, Enrollment, Double-Blind, Vehicle-Controlled Trial of An Investigational Medication Tape for the Treatment of Pain Due to Carpal Tunnel Syndrome and its Symptoms

A Study to Determine the Efficacy and Safety of an Investigational Medication in Non-Q-Wave Coronary Events: A Double-Blind, Randomized, Parallel Group, Multicenter Study Comparing an Investigational Medication and Intravenous Unfractionated Heparin

An Open-Label, Randomized, Controlled, Multi-Center Clinical Trial to Evaluate an Investigational Medication Compared to Cleocin in the Treatment of Bacterial Vaginosis

A Comparison Study of Adding an Investigational Medication Versus Doubling the Dose of Beclovent in Asthmatic Subjects Symptomatic on Existing Inhaled Corticosteroids

A l-Year, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of an Investigational Medication in NIDDM Patients With Hyperlipidemia

A Multicenter, Double-Blind, 26-Week Study Comparing the Efficacy and Safety of an Investigational Medication to Simvastatin in NIDDM Patients With Hyperlipidemia